Comparison of the Efficacy of Systemic Antibiotics and Systemic Retinoids in Hidradenitis Suppurativa.
- Author:
Jung Eun SEOL
1
;
So Hee PARK
;
So Young JUNG
;
Sung Hwan HWANG
;
Han Young WANG
;
Hyojin KIM
;
Jong Keun SEO
;
In Ho PARK
Author Information
1. Department of Dermatology, Inje University Busan Paik Hospital, Busan, Korea. derma09@hanmail.net
- Publication Type:Original Article
- Keywords:
Hidradenitis suppurativa;
Isotretinoin;
Tetracycline
- MeSH:
Abscess;
Anti-Bacterial Agents*;
Biological Products;
Buttocks;
Hidradenitis Suppurativa*;
Hidradenitis*;
Humans;
Immunologic Factors;
Isotretinoin;
Male;
Recurrence;
Retinoids*;
Skin Diseases;
Tetracycline;
Therapeutic Uses
- From:Korean Journal of Dermatology
2017;55(10):651-656
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Hidradenitis suppurativa is a chronic inflammatory skin disease showing recurrent painful nodules and abscesses. Many treatment modalities, such as topical antibiotics, systemic antibiotics, retinoids, immunomodulators, biologics, and surgical treatment are used to treat the disease, but there is no single effective treatment for hidradenitis suppurativa. OBJECTIVE: We conducted this study to compare the clinical outcomes of treatment with systemic antibiotics and systemic retinoids. METHODS: We analyzed the clinical features, treatment modalities, and clinical outcomes of patients with hidradenitis suppurativa and compared the clinical outcomes of treatment modalities. RESULTS: A total of 77 patients were enrolled. Male patients were predominant, and the mean age was 28.1 years. Buttock (42.0%) was the most commonly affected site and 63 patients (81.8%) had lesions at Hurley stage I. Forty-eight patients (62.3%) were treated with systemic antibiotics and 29 (37.7%) with systemic retinoid. Seventy-one patients (92.2%) showed improvement after a mean treatment duration of 8.3 weeks, and 69 (89.6%) experienced recurrence after improvement. Systemic antibiotics showed a relatively high improvement rate, short mean treatment duration, and low recurrence rate compared with systemic retinoids, but the differences were not statistically significant. Among systemic antibiotics, both tetracycline and macrolide showed good therapeutic effects for HS, but the differences were also not statistically significant. CONCLUSION: In this study, systemic antibiotics were associated with superior treatment outcomes compared to systemic retinoids, though without statistical significance. In the case of mild lesions, treatment with systemic retinoids appears to show comparable effectiveness to systemic antibiotics.
